JOB OFFERS MEETINGS 2017 in France
←
→
Transcription du contenu de la page
Si votre navigateur ne rend pas la page correctement, lisez s'il vous plaît le contenu de la page ci-dessous
Position available for an Assistant-‐Professor in Vascular Biology at University Grenoble-‐Alpes (France) Specifications of the position: Young researcher keen on innovative in vivo technologies for the study of blood and/or lymphatic vessel development Teaching duties: Physiology (animal experimentation, genetically engineered mouse models for biological research) License and Master students Research duties: Development of a personal research program on vascular biology in the Team « BMPs in angiogenesis and lymphangiogenesis » headed by Dr Sabine Bailly. Within the Grenoble Institute for Biosciences and Biotechnologies (BIG, 300 fellows), the Laboratory Biology of Cancer and Infection (BCI, UMR_S 1036, INSERM-‐UGA-‐CEA), headed by Dr Jean-‐Jacques Feige, is a research lab (around 60 people) that has a strong international recognition in the field of vascular biology. The laboratory studies the developmental formation of new vessels (angiogenesis and lymphangiogenesis) as well as the cellular interactions of bacteria and metastatic tumor cells with the vasculature. It uses molecular and cellular techniques and aims at integrating its pathophysiological observations in various murine models of human pathologies. The lab is associated with IDEX “Université Grenoble-‐Alpes : Université de l'Innovation“ and LABEX GRAL (Grenoble Alliance for Integrated Structural and Cell Biology), two local scientific networks supported by University Grenoble-‐Alpes (UGA). In the BIG Institute, members of the lab have access to several highly efficient technological platforms: SPF mouse facility equipped with bioluminescence/fluorescence imagers, mass spectrometry and high-‐content screening platforms, high resolution optical microscopy, last generation FACS. The BCI laboratory wants to hire a young Assistant Professor (Maître de Conférences) who will benefit from a « Chaire Mixte INSERM » for 5 years. This implies that teaching schedule is limited to one-‐third of normal duty for the initial five years. The Assistant professor will perform his research in the team headed by Dr Sabine Bailly and will develop his own program in interaction with the team’s research interests. This team currently studies the role of BMP9/ALK1 signaling pathway in blood and lymphatic vessel development and aims at developing innovative targeted therapeutic strategies for the treatment of cancer and several hereditary vascular diseases (Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension). The candidate should have a PhD degree in biological sciences and a successful post-‐doctoral experience in vascular biology. He should have experience in cellular signaling and in murine models of vascular diseases or dysfunctions (conditional tissue-‐specific gene knock-‐outs, transgenic animals expressing lineage-‐specific fluorescent markers, tumor models, or other). An experience in “omic“ analyses on small size biological samples or in in vivo imaging would be appreciated as well as scientific knowledge of vascular pathologies. Contacts: Dr. Jean-‐Jacques Feige, Head of BCI Laboratory, jean-‐jacques.feige@cea.fr Dr. Sabine Bailly, Head of the BCI/BAL team, sabine.bailly@cea.fr Laboratoire Biologie du Cancer et de l'Infection Unité Mixte de Recherche INSERM-‐CEA-‐UGA-‐CNRS U1036 Institut de Biosciences et Biotechnologies de Grenoble tél. (33) 04 38 78 47 27 Fax. (33) 04 38 78 50 58 Website : http://www.cea.fr/drf/big/BCI
Proposition de chaire mixte INSERM-‐UGA CNU : section 65 ou 66 CSS 3 – Physiologie et physiopathologie des grands systèmes CSS 2 – Pathologie du développement, hématologie et cancérologie Argumentaire pour la proposition de chaire mixte INSERM-‐UGA dans l’unité 1036-‐Equipe BAL Profil : Technologies innovantes pour l’étude in vivo du développement des vaisseaux sanguins et lymphatiques Au sein de l’Institut de Biosciences et Biotechnologies de Grenoble (BIG, 300 personnes), le laboratoire de Biologie du Cancer et de l’Infection (BCI, UMR_S 1036, INSERM-‐UGA-‐CEA), dirigé par Jean-‐Jacques Feige, est une Unité de recherche d’environ 60 personnes, organisée en 3 équipes de recherche, avec un positionnement international fort dans l’étude des vaisseaux sanguins au cours du développement, de l’invasion tumorale et de l’infection bactérienne. Le laboratoire met en jeu des approches moléculaires et cellulaires et vise à intégrer ses observations physiopathologiques en utilisant des modèles murins de diverses pathologies. Le laboratoire BCI/U1036 est membre de l’IDEX grenoblois “Université Grenoble-‐ Alpes : Université de l'Innovation“ et du LABEX GRAL (Grenoble Alliance for Integrated Structural and Cell Biology). L’Institut BIG dispose de plateaux technologiques performants : Animalerie EOPS équipée d’imageurs de bioluminescence/fluorescence, plateformes IBISA de protéomique et de criblage HTS de chimiothèques, plateforme de microscopie optique haute résolution µLife, FACS de dernière génération. La chaire mixte INSERM-‐UGA est proposée pour recruter un(e) jeune maitre de conférences au sein de l’équipe du Dr Sabine Bailly dans le but de renforcer cette équipe de recherche et d'augmenter sa compétitivité au niveau international dans le domaine de la vascularisation sanguine et lymphatique. La thématique scientifique de l'équipe est l'étude d’une voie de signalisation (voie des bone morphogenetic proteins BMP9/10 et de leur récepteur ALK1) dans le développement des vaisseaux sanguins et lymphatiques afin de proposer de nouvelles approches thérapeutiques ciblées dans les pathologies vasculaires et la cancer. Pour cela, l’équipe développe 3 axes de recherches: -‐ Étude des rôles respectifs de BMP9 et BMP10 dans le développement sanguin et lymphatique -‐ Étude de l'implication de BMP9 et BMP10 dans deux pathologies vasculaires : la maladie de Rendu-‐Osler encore appelée HHT pour (Télangiectasie Hémorragique Héréditaire) et l'hypertension artérielle pulmonaire -‐ Étude de l'implication de BMP9 et BMP10 dans le développement tumoral et la dissémination métastatique : ALK1 comme cible thérapeutique. Le(la) candidat(e) au poste de Maitre de Conférences aura effectué une thèse et un stage postdoctoral en biologie cellulaire et moléculaire avec utilisation de modèles murins dans le domaine vasculaire. Il/elle possèdera une expertise forte en signalisation cellulaire ainsi qu'une très bonne expertise dans la manipulation de modèles murins (souris invalidées de façon conditionnelle et tissu-‐spécifique, souris exprimant des marqueurs fluorescents lignage-‐spécifiques, modèles tumoraux). Une expérience des analyses “omiques“ à partir de petits échantillons biologiques ou d’imagerie du petit animal serait appréciée. Des connaissances sur les pathologies vasculaires sanguines ou lymphatiques seraient également un atout pour ce poste. Le titulaire de la chaire aura pour mission de développer un axe de recherche dans le cadre de la thématique de l’équipe du Dr Sabine Bailly. Elle/Il cherchera à mettre en place de nouveaux modèles murins génétiquement modifiés pour étudier les processus moléculaires et cellulaires conduisant au remodelage des vaisseaux sanguins et lymphatiques. Elle/Il développera au sein de l'équipe, et en relation avec d’autres équipes du Laboratoire BCI et de l’Institut BIG, de nouvelles approches innovantes pour étudier le développement vasculaire.
Opening of the HEARING INSTITUTE in the heart of PARIS Group Leader positions The Hearing Institute, an auditory neuroscience research institute, aims to advance our knowledge of auditory signal processing from the sensory organ to the brain, auditory perception and cognition, multisensory and sensorimotor integration, in healthy and pathological conditions. It will do this by bringing together teams of scientists from diverse fields, ranging from biophysics, acoustics, neurobiology, molecular and cellular biology, and genetics, to bioinformatics and computational neuroscience, all highly committed to interdisciplinary research. The Hearing Institute which will be associated with a dedicated clinical center, also aims to develop innovative therapeutic approaches (from engineering solutions to pharmaceutical and biological agents) to hearing and balance disorders. The Hearing Institute and the nearby Vision Institute will form a campus at the cutting edge in basic sensory neuroscience and related innovations towards patients. It will also enjoy close interactions with Institut Pasteur and the Université Pierre et Marie Curie. The Hearing Institute will house core facilities for electrophysiology, imaging (cell, sensory organ and brain), biochemistry, molecular and cellular biology, bioinformatics, genetics and behavior and will have its own animal housing. Sponsored by Bettencourt- Schueller Foundation and 'Agir pour l’Audition' Foundation and ‘Voir et Entendre’ Foundation, the Hearing Institute will be run under the auspices of Université Pierre et Marie Curie (UPMC-Paris-Sorbonne Universités), the French National Institute of Health and Medical Research (INSERM), Institut Pasteur, the French National Center for Scientific Research (CNRS) and Collège de France. Various funding opportunities are available. Both senior and junior group leader applications will be considered. Appointments will be made from junior through to senior level, depending on experience. Preference will be given to ambitious objectives addressing major challenges in the abovementioned fields. The deadline for applications is January 15th, 2017. PIs selected by the Hearing Institute Scientific Committee will be contacted directly and invited for interviews in March-April 2017. The Hearing Institute will open in April 2018. Applications, including: -A full CV, including a list of publications -Past and current research achievements (2 pages) -The research proposal (5 pages) -Two letters of recommendation should be sent to Pr. Christine Petit :christine.petit@pasteur.fr, who can also be contacted for additional information and Patty Manent, Executive Secretary
Français | English Brain Plasticity Laboratoire Unit Plasticité du Cerveau CNRS CNRS Paris - ESPCI UMR 8249 Home | Research | Where to find us | Contacts Editorial About About thethe Laboratory Laboratory The ability to learn, i.e. to alter behaviour according to previous experience, is certainly one The of the ability to learn,property most fascinating i.e. toofalter behaviour the nervous according system. to previous Such a capacity depends on the experience, inherent is certainly exibility, one or plasticity, of the most of neuronal fascinating networks and synapseproperty of the activity. The cellular and nervous system. Such a capacity depends on the inherent flexibility, molecular mechanisms underlying this fundamental and conserved process are far or from being elucidated, nor how the proper balance between stabilised networks and adaptability is plasticity, of neuronal networks and synapse activity. The cellular equilibrated to ensure brain stability. Molecular and cellular interactions play a crucial and molecular instructive rolemechanisms underlying in neuronal plasticity. Speci cthis fundamentalorand neurotransmitters conserved neuromodulators, process released byare localfar from being interneurons, canelucidated, nor how regulate e ciently the proper (but how?) balance remodelling of synapses, neurites or functional circuits. Finally, devastating neuropathologies can a ect cognitive between stabilised networks and adaptability is equilibrated to ensure ability, as in the cases of inherited mental retardation or Alzheimer’s disease brain stability. Molecular and cellular interactions [http://en.wikipedia.org/wiki/Alzheimer%27s_disease] playspeci , or alter a crucial c neuromodulator instructive role in neuronal plasticity. Specific neurotransmitters or systems, as in Parkinson’s disease [http://en.wikipedia.org/wiki/Parkinson%27s_disease] . neuromodulators, released by local interneurons, can regulate efficiently (but The how?) ESPCI remodelling ParisTech of synapses, Brain Plasticity Unit, CNRS neurites Unit 8249, or functional headed by Thomascircuits. Preat since Finally, January devastating 1st, 2012, gathersneuropathologies can affect neurobiologists and physicists cognitive interested ability, by brain as in the functioning and neuroplasticity. This laboratory includes about 45 people and is composed of ve cases of inherited mental retardation or Alzheimer’s disease, or alter independent research teams: Zsolt Lenkei (Neuronal Structure and Dynamics), Thomas Préat specific (Genes and neuromodulator dynamics of memorysystems, as inBirman systems), Serge Parkinson’s (Genes, disease. Circuits, Rhythms and Neuropathology), François Vialatte (Brain‑computer Interfaces) and Karim Benchenane (Memory, Oscillations and Brain states). The ESPCI ParisTech Brain Plasticity Unit, CNRS Unit 8249, headed by Thomas Three Preat related since topics, January 1st,neuromodulation i.e. neuroplasticity, 2012, gathers and neurobiologists applied studies and of various physicists interested neuropathologies, by brain are addressed functioning in this and Laboratory by neuroplasticity. an integrated This multidisciplinary approach combining genetics, molecular and cellular biology, advanced imaging methods, laboratory includes about 45 people and is composed of five independent electrophysiology and behaviour tests. Complementary neurobiological models are being research studied, fromteams: the single neuron to y and mammalian integrated circuits. The insertion of Zsolt the Lenkeiin(Neuronal Laboratory Structure the ESPCI ParisTech andallows campus Dynamics) fruitful exchanges between Thomas Préat (Genes and dynamics of memory neurobiologists and other scientists, all the more since systems) experienced physics scientists or students, who are acquainted with both scienti c elds, are present in our laboratory. Serge Birman (Genes, Circuits, Rhythms and Neuropathology) François Vialatte (Brain-computer Interfaces) Karim Benchenane (Memory, Oscillations and Brain states). NEWS Job Offer Three related topics, i.e. neuroplasticity, neuromodulation and applied The Brain Plasticity Unit, CNRS‑ESPCI Paris, studies of various neuropathologies, are addressed in this Laboratory by currently comprises 5 teams and hosts 50 (...) an integrated multidisciplinary approach combining genetics, molecular and cellular biology, advanced imaging methods, electrophysiology and > More news... behaviour tests. Complementary neurobiological models are being studied, from the single neuron to fly and mammalian integrated circuits.Top The insertion of the Laboratory in the ESPCI ParisTech campus allows fruitful exchanges between neurobiologists and other scientists, all the more since experienced physics scientists or students, who are acquainted with both scientific fields, are present in our laboratory.
Français | English Brain Plasticity Laboratoire Unit Plasticité du Cerveau CNRS CNRS Paris - ESPCI UMR 8249 Home | Research | Where to find us | Contacts Editorial Job Offer About the Laboratory Junior group leader The ability to learn, i.e. to alter behaviour according to previous experience, is certainly one The of the Brain Plasticityproperty most fascinating Unit, CNRS-ESPCI of the nervousParis, system.currently comprises Such a capacity depends5on teams the and hosts inherent 50 scientists, exibility, students, or plasticity, of neuronaland staff.and networks Thesynapse Unit isactivity. headed Theby cellular and Thomasmechanisms molecular Preat. Ourunderlying work focuses on understanding this fundamental and conserved brain plasticity process in are far from being elucidated, nor how the proper balance between stabilised networks and adaptability is physiological conditions and in various neuropathologies. We carry equilibrated to ensure brain stability. Molecular and cellular interactions play a crucial out highly collaborative instructive role in neuronaland multi-disciplinary plasticity. studies using Speci c neurotransmitters a variety of or neuromodulators, modelby released organisms. The insertion local interneurons, of the can regulate Brain(but e ciently Plasticity Unit in the how?) remodelling ESPCI of synapses, neurites or functional circuits. Finally, devastating neuropathologies can a ect cognitive campus, which enjoys a strong culture of scientific excellence (6 Nobel ability, as in the cases of inherited mental retardation or Alzheimer’s disease prizes), allows fruitful exchanges between neurobiologists [http://en.wikipedia.org/wiki/Alzheimer%27s_disease] , or alter speci and other c neuromodulator scientists including physicists. systems, as in Parkinson’s disease [http://en.wikipedia.org/wiki/Parkinson%27s_disease] . We are seeking to recruit a junior group leader. Applicants who develop an ESPCI The integrated ParisTech physiological Brain Plasticity approach, Unit, CNRS Unit such as studies 8249, headed by combining Thomas Preat since molecular January genetics 1st, 2012, gathers and functionaland neurobiologists brain imaging, physicists will bebyconsidered interested in and brain functioning neuroplasticity. This laboratory includes about 45 people and is composed of ve priority. independent research teams: Zsolt Lenkei (Neuronal Structure and Dynamics), Thomas Préat Candidates (Genes mustofhold and dynamics a French memory systems),institutional Serge Birmanresearch position (Genes, Circuits, (CNRS, Rhythms and INSERM etc.), or they must meet criteria to obtain a French starting grant Neuropathology), François Vialatte (Brain‑computer Interfaces) and Karim Benchenane (Memory, Oscillations and Brain states). (such as Atip-Avenir) and a French institutional research position. Women Three are related encouraged topics, to apply. i.e. neuroplasticity, neuromodulation and applied studies of various Interested candidates neuropathologies, are addressedshould send in this a full CV, Laboratory by ana integrated brief description of their multidisciplinary approach combining genetics, molecular and cellular biology, advanced imaging methods, research achievements and of their projects, and a personal statement, electrophysiology and behaviour tests. Complementary neurobiological models are being to Thomas studied, Preat from the singlevianeuron email:to thomas.preat@espci.fr y and mammalian integrated circuits. The insertion of There the is no specific Laboratory in the ESPCI deadline ParisTechfor the application campus allows fruitful because exchanges the selection between process will be ongoing until a successful candidate has beenscientists neurobiologists and other scientists, all the more since experienced physics identified. or students, who are acquainted with both scienti c elds, are present in our laboratory. NEWS Job Offer For more information: The Brain Plasticity Unit, CNRS‑ESPCI Paris, https://www.bio.espci.fr/-Home- currently comprises 5 teams and hosts 50 (...) https://www.espci.fr/en/ > More news... Top
Junior group leader The Brain Plasticity Unit, CNRS-‐ESPCI Paris, currently comprises 5 teams and hosts 50 scientists, students, and staff. The Unit is headed by Thomas Preat. Our work focuses on understanding brain plasticity in physiological conditions and in various neuropathologies. We carry out highly collaborative and multi-‐disciplinary studies using a variety of model organisms. The insertion of the Brain Plasticity Unit in the ESPCI campus, which enjoys a strong culture of scientific excellence (6 Nobel prizes), allows fruitful exchanges between neurobiologists and other scientists including physicists. We are seeking to recruit a junior group leader. Applicants who develop an integrated physiological approach, such as studies combining molecular genetics and functional brain imaging, will be considered in priority. Candidates must hold a French institutional research position (CNRS, INSERM etc.), or they must meet criteria to obtain a French starting grant (such as Atip-‐Avenir) and a French institutional research position. Women are encouraged to apply. Interested candidates should send a full CV, a brief description of their research achievements and of their projects, and a personal statement, to Thomas Preat via email: thomas.preat@espci.fr There is no specific deadline for the application because the selection process will be ongoing in 2016 until a successful candidate has been identified. For more information: https://www.bio.espci.fr/-‐Home-‐ https://www.espci.fr/en/
Institut des Neurosciences Cellulaires & Intégratives CNRS UPR-3212 - Strasbourg, France http://inci.u-strasbg.fr/fr/index.html International Call for New Group Leaders INCI is a leading French biological Research Center, affiliated to CNRS and the University of Strasbourg with 9 independent research groups focusing their activity on three priority axes: - Communication and networks in the nervous system deciphering the mechanisms involved in neurotransmission and neuroendocrine secretion (exocytosis, endocytosis, membrane fusion), and the physiology of neural networks (circuits and information in the cerebellar cortex and olfactory); - Nociception and pain interested in nociceptive signaling mechanisms in the spinal cord, chronic pain (anatomo-functional approach and treatments), molecular determinants of pain in the brain and comorbidities of pain; - Neurobiology of rhythms focusing on rhythms and pathologies in the retina, regulation of circadian clocks in the central nervous system, melatonin and seasonal rhythms and sleep regulations. INCI will recruit outstanding scientists addressing biological questions in line with its priority axes. The newly recruited group will benefit from the expertise and state-of-the-art facilities of the INCI Institute in molecular biology (quantitative PCR, laser micro-dissection, genomics, optogenetics, transgenic mice), proteomics (HPLC-MS, flow cytometry, subcellular fractionation), in vitro and in vivo electrophysiology (ionic currents, synaptic signals), cell imaging (confocal and bi-photonic microscopy, time-lapse, calcium imaging, bioluminescence), ultrastructure imaging (electron transmission and scanning microscopy), anatomy (tracing of neural pathways, stereotaxic lesions), in vivo functional exploration (behavioral tests using animal models for anxiety, pain and depression, cerebral micro-dialysis on freely moving animals, actimetry and telemetry, sleep rhythm recordings). Appropriate laboratory and office space, depending on group size, will be available to the selected group leader(s). The candidates must meet criteria to compete for national and international research funding (ATIP/Avenir Program, FRM Jeune Equipe, ERC Starting Grant) and for French institutional research and/or teaching positions (CNRS, University). Applications should include : - INCI: Ressources humaines au 1er janvier 2014 CV (1-2 pages); - List of publications, patent applications, invited conferences, awards and grants; - Description (2-3 pages) of the research project; - Two letters of reference. Applications or further inquiries should be sent to Marie-France Bader (badermf@inci- cnrs.unistra.fr) or Michel Barrot (mbarrot@inci-cnrs.unistra.fr - Tel : 03 88 45 66 33)
CALL for NEW RESEARCH GROUP LEADERS, CLERMONT-FERRAND, FRANCE Deadline ……..July 1st 2017 The Genetics, Reproduction and Development (GReD) laboratory (www.gred-clermont.fr) is a multi-disciplinary CNRS-INSERM-University research institute on the medical campus of the University Clermont-Auvergne (35,000 students) the main university in central France, localised in the lively city of Clermont-Ferrand, with attractive living conditions and peaceful natural environment. The GReD consists of 13 groups with research interests ranging from genome dynamics and epigenetic control, development and stem cell biology to endocrinology and cancer. Teams use Arabidopsis, Drosophila and mice as models to address questions of fundamental biology and their application to human health and well-being. Successful candidates will have access to office and lab space for a team to up to 10 persons in a brand-new 4500 m2 building. The GReD laboratory offers access to state-of- the-art core services, including up-to date cell imaging and histology platforms, single cell genomic technologies, transgenic animal (mouse, Drosophila) and plant facilities. Facilities for high-throughput sequencing, mass spectrometry, proteomics, FACS sorting, electron microscopy and radiobiology are available on the multidisciplinary Medical School campus. We open two distinct calls: 1. Non-thematic call. Open call for group leaders addressing cutting-edge scientific biological questions, with a special focus on model organism-based research falling within the scientific missions of the Institute. 2. Systems biology / bioinformatics. We are seeking to recruit a group focusing on whole genome data analysis, gene regulatory networks or modelling of biological processes in order to strengthen GReD’s expertise in this fast growing field. We encourage both young and already established outstanding researchers to apply. Applications (in English, specifying the call reference as the subject of the email) should include a curriculum vitae a short description of achievements and a record of self- financing, accompanied by the proposed research program and contact details for 3 professional references. The deadline for applications is July 1st 2017. Selected applicants will be interviewed in October 2017. Please send your application as a single PDF file of approximately 6/10 pages named LASTNAME_GReD_2017.pdf to direction.gred@udamail.fr. Any enquiries should also be sent to this address.
CHEMICAL BIOLOGY JUNIOR GROUP LEADER POSITION Institut Curie –Paris, France 26, rue d’Ulm 75248 Paris Cedex 05 Institut Curie (http://www.curie.fr) is constituted of a hospital and a world-class multidisciplinary research center combining research in cell biology, genetics, epigenetics, immunology, soft matter physics, organic and medicinal chemistry. It includes over 3,000 researchers, physicians, clinicians, technicians and administrative staff working on three sites: Paris, Orsay and Saint-Cloud. The institute facilities include advanced imaging, high throughput sequencing, bioinformatics, small molecule collection, reverse phase protein array, proteomics and mass spectrometry, antibody technologies, cytometry, and animal housing (https://science.institut-curie.org/platforms/). In addition, the proximity with the hospital allows access to large clinical databases and sample collections. As part of one of its strategic research domain entitled “Multiscale Physics-Biology-Chemistry”, Institut Curie is supporting the recruitment of an outstanding chemical biologist as Junior Group Leader in the Chemical Biology of Membranes and Therapeutic Delivery unit (UMR3666 CNRS — U1143 INSERM; http://chemicalbiology.curie.fr) on its research site in central Paris located in an exceptional scientific environment within PSL University. The newly recruited group leader will benefit from the expertise of this unit in cell biology, chemical biology, organic synthesis, and supramolecular chemistry, and from state-of-the-art research equipment. Appropriate laboratory space for 6-8 people and a start-up package will be available. Successful candidates should meet criteria to obtain national and international funding, and for French institutional research positions (CNRS or Inserm). Applications must comprise a personal statement explaining why you are interested in joining Institut Curie, a 3-4 page research plan, a full CV detailing publications, patents, invited conferences, awards, grants, training and teaching experience, and contact details of 3-5 individuals who can be contacted for recommendation letters. Send these material to Ludger Johannes at ludger.johannes@curie.fr. Deadline for applications: December 15, 2016 Short-listed candidates will be informed by January 15, 2017, and invited to the Curie Institute by mid-February 2017
Post DOC POSITION
Ecole Polytechnique - University Paris-Saclay PI: Alexis GAUTREAU alexis.gautreau@polytechnique.edu https://portail.polytechnique.edu/bioc/en/gautreau OFFER For PHD or Post Doctoral POSITION Isolation of novel tumor suppressor genes that monitor the actin cytoskeleton Polymerization of branched actin by the Arp2/3 complex drives membrane protrusion during cell migration. In this process, the Arp2/3 complex is activated by the WAVE complex and inhibited by Arpin, which we have recently discovered. In most invasive tumors in the breast, there is either up-regulation of the WAVE complex or down-regulation of Arpin. These alterations are associated with a poor prognosis for breast cancer patients. We have shown that this signaling pathway controls cell migration and proliferation in a coordinated manner. To identify the genes that monitor the actin cytoskeleton, we have performed a genome-wide RNAi screen and found about 15 potential tumor suppressor genes, which allow cells arrested in their cell cycle by Arp2/3 inhibition to resume cell cycle progression. The goal of this PhD is to validate some of these candidates. To this end, the student will perform a secondary screen by obtaining KO of these genes in an immortalized human breast cell line or a breast tumor cell line, using the CRISPR-Cas9 technology. The positive hits that transform the immortalized line and renders the tumor cell line invasive will be further studied. We will address the localization of these tumor suppressor genes and their cellular function. We expect the hits to localize to the branched actin networks of membrane protrusions and to regulate cell migration. We will look for protein partners of the hits using proteomics in order to understand how they perform their function and how they are regulated. 5 representative publications of the group: • Lomakina ME, Lallemand F, […], Bièche I, Alexandrova AY, Gautreau A. 2016. Arpin down- regulation in breast cancer is associated with poor prognosis. Brit J Cancer 114 :145-63. • Gorelik R, Gautreau A. 2015. The Arp2/3 inhibitory protein Arpin induces cell turning by pausing cell migration. Cytoskeleton 72:362-71. • Krause M, Gautreau A. 2014. Steering cell migration: lamellipodium dynamics and the regulation of directional persistence. Nature Review Mol Cell Biol 15:577-90. • Gorelik R, Gautreau A. 2014. Quantitative and unbiased analysis of directional persistence in cell migration. Nature Protocols 9:1931-43. • Dang I, Gorelik R, Sousa-Blin C, […], Faix J, Blanchoin L, Gautreau A. 2013. Inhibitory signalling to the Arp2/3 complex steers cell migration. Nature 503:281-4.
! ! A post-doctoral position is available for up to 2.5 years in the laboratory of Anne Blangy, at the CRBM in Montpellier – France, starting March 1rst, 2017: "Actin and microtubule cross-talk in cell adhesion". The project aims to investigate actin and microtubule crosstalk in cell adhesion, using the osteoclast as a model system. The bone resorption apparatus of osteoclast is a unique adhesion structure made of a belt of densely packed podosomes sustained by a dense network of actin cables and microtubules. Our aim is to understand the molecular architecture and signaling pathways among this complex structure, which confers to the osteoclast its unique ability to degrade the bone. The post holder will use a variety of advanced imaging technics - including super-resolution microscopy, live cell microscopy and automated imaging – cytoskeleton signaling approaches and functional bone resorption assays. The Cell Biology Research Center of Montpellier (CRBM, http://www.crbm.cnrs.fr) is a dynamic research institute internationally recognized for its basic research in cell biology. It is located in a new building in Montpellier (South of France) on a multidisciplinary campus of the French National Center for Scientific Research (CNRS). Research at the institute covers fundamental and translational aspects of biology, with specific focus on cell signaling and cytoskeleton dynamics, cell cycle regulation, gene regulation and systems biology of evolution and molecular biophysics and structural bioinformatics. The CRBM imaging facility is part of Montpellier RIO Imaging platform with access to the latest technologies in microscopy, including confocal, spinning disk, 3D-SIM and automated imaging. The successful candidate will have a PhD in Life Science and have a strong experience in the cell biology of the cytoskeleton. Good skill in fluorescence imaging, in particular super- resolution approaches, will be particularly appreciated. For additional information please contact Anne Blangy (anne.blangy@crbm.cnrs.fr) Selection of recent publications: - Touaitahuata H. et al., J Cell Sci. 2016 Sep 15;129(18):3449-61. - Vives V, Cres G, et al., Nat Commun. 2015 Feb 3;6:6218 - Touaitahuata H. et al., Dev Biol. 2014 Sep 1;393(1):57-70.
Christophe LAMAZE, PharmD, PhD Ins2tut Curie, Paris France UMR 3666 CNRS / U1143 INSERM Team “Membrane Dynamics and Mechanics of Intracellular Signaling” Keywords: caveolae, high resolu2on imaging, mechanobiology, cancer, 3D models 2 YEARS- FUNDED POSTDOC POSITION: Exploring Caveolae-Mediated Mechanotransduc2on in Cancer A postdoctoral fellow posi0on is immediately available at the “Membrane Dynamics and Mechanics of Intracellular Signaling” Team at the Curie Ins0tute in Paris (France). The project is at the crossroads of cell biophysics and cancer-related mechanotransduc0on. It aims at iden0fying the molecular mechanisms by which caveolae mediate the cell response to mechanical stress (Sinha et al., 2011 Cell). We will inves0gate how caveolae mechanical flaNening controls pro- or an0-cancer signaling responses through the sensing of the mechanical forces present during tumor mass evolu0on in breast cancer and melanoma. The present project is part of a collabora0ve program that integrates cell biology, signaling proteomics, 3D-tumor models (alginate capsules), high resolu0on imaging (fluorescence correla0on spectroscopy, intravital and correla0ve in vivo microscopy), mechanical stress devices and forces measurements. The successful candidate will be a highly mo0vated person, with good communica0on skills and a solid background in cell biology and/or biophysics. Ideally, s/he will have used cell imaging techniques during his/her Ph.D. work. Knowledge in membrane trafficking will be an advantage. Interested candidates should send an email with curriculum vitae, statement of research interest and names of three references to: christophe.lamaze@curie.fr. More info @ hNps://science.ins0tut-curie.org/team-lamaze Poten2al roles of caveolae flaVening Recent publica2ons: in mechanosignaling. (Nassoy and Lamaze, TCB 2012). 1. Blouin et all.,( 2016). Glycosyla0on-Dependent IFN-gammaR Par00oning in Lipid and Ac0n Nanodomains Is Cri0cal for JAK Ac0va0on Cell 166:920-34. 2. Lamaze, C., and Torrino, S. (2015). Caveolae and Cancer: A New Mechanical Perspec0ve. Biomedical journal 38, 367-379. 3. Alessandri et al. (2013). Cellular capsules as a tool for mul0cellular spheroid produc0on and for inves0ga0ng the mechanics of tumor progression in vitro. Proc Natl Acad Sci U S A 110, 14843-14848. 4. Sinha et al., 2011. Cells respond to mechanical stress by rapid disassembly of caveolae. Cell. 144:402-13.
Post-doctoral position in Toulouse, France Consequences of regulatory T cell-recirculation to the thymus We are seeking a highly motivated and dynamic young scientist for a post-doctoral position in the ‘T cell-mediated immune tolerance’ laboratory (www.immune-tolerance.fr) headed by Prof. Joost van Meerwijk at the ‘Center of Pathophysiology of Toulouse Purpan’ (CPTP), Toulouse, France. The position, financed by the ANR, is available starting spring 2017 for one year with the possibility of renewal. Our research focuses on the biology of regulatory T lymphocytes (Treg), from their development in the thymus to their pre-clinical application for the induction of transplantation-tolerance (e.g. Joffre et al., Nature Medicine 2008). We have recently shown that the development of regulatory T cells is controlled by a negative feedback loop exerted by peripheral Treg reentering the thymus and inhibiting the differentiation of their precursors (Thiault et al., Nature Immunol. 2015). The goal of the project the successful candidate will work on is to determine the consequences of Treg recirculation on T cell repertoire selection in the thymus and on susceptibility to autoimmune pathology. The applicant must have shown research abilities and capabilities to perform a collaborative project within a team, and possesses good written and verbal communication skills in English. Applicants must have training and research-experience in molecular biology, gene expression analysis, and bioinformatics (generation of libraries, RNA sequencing and analysis of high throughput sequencing data). Our Center offers a stimulatory intellectual and collaborative environment and well-equipped core facilities. Applicants should e-mail before January 1st 2017 their motivation letter, CV, and contact information of two references with whom they have worked to: Joost.van-Meerwijk@inserm.fr and Paola.Romagnoli@inserm.fr
Mechanotransduction associated with integrin-mediated phagocytosis Institut Cochin, Paris, France Phagocytosis is the mechanism of internalization of large particles of several microns in size and therefore, as other cellular functions dealing with large scales, it involves important mechanical constraints (Niedergang Encyclopedia of Cell Biology 2016, Marion Dev Cell 2012, Dumas J Cell Biol 2015, Marie-Anaïs Traffic 2016, Marie- Anaïs J Vis Exp 2016). The project focuses on the integrins’ family of cell adhesion receptors that signal through the plasma membrane in both directions. We propose to investigate actin- binding proteins, and their associated regulators, as mechanosensitive hubs at the center of feedback loops that control anchoring to the actin cytoskeleton and activation of the integrins during phagocytosis in macrophages. The objectives of the project are to dissect the mechanisms by which mechanosensitive protein machineries sense force and modulate actin dynamics and anchoring during CR3-mediated phagocytosis. The team “Biology of Phagocytes” is part of the “Infection, Immunity and Inflammation” Department at Institut Cochin. Institut Cochin is a large research centre that provides multidisciplinary environment and exquisite technology platforms. The project is led in collaboration with Christophe Le Clainche (Ciobanasu Eur J Cell Biol 2013, Nat Comm 2014, Nat Protoc 2014), who developed a new microscopy assay to reconstitute and characterise actomyosin-dependent mechanosensitive machineries with pure proteins on geometrically-defined micropatterned surfaces. We are seeking a motivated candidate with a PhD, preferably in cell biology and/or biophysics. Background in microscopy, exposure to live-cell imaging, mathematical modeling and biophysical methods are desirable. Contract : two years. Interested applicants should contact Florence Niedergang with a CV and name of references. Florence Niedergang, Team Biology of Phagocytes Institut Cochin (Inserm U1016, CNRS UMR8104, Université Paris Descartes) 22, rue Méchain, 75014 Paris, France Email : Florence.Niedergang@inserm.fr; Tel : 33(1) 40 51 64 21 website: http://cochin.inserm.fr/Departements/ih/equipe-niedergang/ http://NiedergangLab.free.fr
Post-‐doc in Reproductive Biology – IBPS PARIS We are looking for a postdoctoral candidate to work on mitochondrial inheritance. We are interested in understanding the cell and developmental mechanisms of uniparental and maternal mitochondrial genome inheritance. The lab is currently investigating how sperm mitochondria are targeted for degradation and how maternal contribution remains homoplasmic throughout generations. We are using live imaging and genetic screens on C. elegans to tackle these two fundamental questions. Financing for this postdoc is available initially for 12 months with the possibility for renewal. Our group is part of the IBPS (Institut de Biologie Paris-‐Seine) in the Department of Developmental Biology. Our Institute is located on the campus of University Pierre and Marie Curie in the heart of Paris. State-‐of-‐the-‐Art imaging equipment is available in the lab and in the facility. The candidate is expected to be a PhD, with no or max. 2 years of postdoctoral experience and with a solid background in Cell Biology/Molecular Biology. Experience with live cell imaging will be an advantage. He/she should be interested in reproduction and mitochondrial inheritance. The candidate should be fluent in English, and is expected to have obtained/obtain at least one first author publication in a peer-‐reviewed journal from his/her PhD work. lnterested candidates should send their CV including research interests and contact details of two referees in a single pdf file to vincent.galy@upmc.fr. Priority will be given to applications received before September 15th, but the position will remain open until a suitable candidate has been found. Cel-‐HD team (http://dev-‐nematode.snv.jussieu.fr/) University Pierre et Marie Curie, UMR CNRS 7622, Laboratory of Developmental Biology 9 quai Saint-‐Bernard, 75252 PARIS Cedex 05, France Institute of Biology Paris-‐Seine vincent.galy@upmc.fr / phone : (33) (0)1 44 27 34 94
Vous pouvez aussi lire